After One Clinic Said Yes, the Phone Started Ringing. AIMN Opens Applications for Practices to Be Featured Next.
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
RBI Data Reveals Divergence in Credit Card Spending and Debit Card Cash Withdrawals
-
First-time boat buyers advised to assess full ownership costs
-
Panthers expected to begin 2027 NRL season away from new stadium
-
Planning and preparation can reduce stress of interstate relocation
-
Sweet As app launches restaurant discovery platform
-
Two more arrested in Carrie Mullane suspected murder investigation
-
Phoenix Restaurants Offer Thanksgiving Dinner to Go for Pickup
-
MLA seeks inquiry into reported sectarian gestures on Ormeau Road
-
Mayo school appeals for information after convent and chapel vandalism
-
Louise O’Reilly attacks Simon Harris over unemployment remarks
-
Virginia overwhelms Arkansas 91-72 behind balanced scoring
-
Canadian soldier Aidan Goulding remembered at Vancouver funeral
-
Second major storm brings destructive winds and outages to British Columbia
-
Tayyab Arif hits 57 on Pakistan Test debut against Sri Lanka
-
Godzilla Minus Zero leads North American box office with $31.6m
-
Robert Trujillo discusses literacy and social justice children’s books
-
Advocate calls for coordinated support for children facing trafficking
-
Civil rights advocate William Bill Tucker dies aged 98
-
Medicare Open Enrollment Ends Dec. 7: Review Your Coverage Options
-
Pennsylvania Democrats secure state trifecta in midterm elections
-
US Treasury order targets bank transfers linked to crypto exchange MEXC
-
Godzilla Minus Zero sets foreign-language box-office opening record
-
Nvidia CEO Controversy Sparks Fears of Tighter U.S. AI Chip Curbs for Samsung and SK hynix
-
Eagles record six sacks as rushing attack struggles against Giants
-
Villeneuve teases James Bond casting at Los Angeles museum gala
-
Thames Water seeks to delay £12bn in debt repayments
-
Nottinghamshire launches specialist rural crime policing team
-
Newark boxing gym expands alternative education programme
-
China confirms talks over possible Xi-Putin-Trump summit
-
Democrats consider impeachment drive against Defence Secretary Hegseth
-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Aston Villa Defy History With Rare Victory at Old Trafford
-
Brussels Education Unions Schedule Major November Protest Over Funding and Reforms
After One Clinic Said Yes, the Phone Started Ringing. AIMN Opens Applications for Practices to Be Featured Next.
Aimwell Partners reports inbound interest following its VitalCare of Shelton announcement and invites physicians and healthcare businesses to join its intelligence network.
MIAMI, FL / ACCESS Newswire / October 14, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced that it is accepting applications from physicians, practices, clinics, and healthcare businesses seeking to be featured on its AI-powered healthcare intelligence network.
The invitation follows a stream of inbound inquiries after the company's VitalCare of Shelton announcement, with physicians and practice owners asking how to participate.
"We featured one practice, and the phone started ringing," said John Morgan, CEO of AimwellBio. "That response reinforced what we are building toward: a network that recognizes healthcare professionals and delivers intelligence relevant to their work."
From Visibility to Participation
AimwellBio is developing custom intelligence questionnaires designed to capture each practice's priorities and inform verified, source-traced intelligence tailored to its field. The questionnaires are intended to serve as an entry point to additional platform features the company expects to announce in the coming weeks.
The goal is to connect professional visibility with practical intelligence, giving participating practices a way to identify the clinical, regulatory, and competitive developments that matter to them.
"Independent physicians and specialty practices bring expertise that deserves greater visibility," Morgan said. "We want to put that expertise forward while giving those professionals useful intelligence and opportunities to connect."
Applications Now Open
AimwellBio welcomes applications from qualified physicians, practices, clinics, and healthcare businesses. Selection will consider credentials, practice information, and alignment with the network's published methodology and standards for verified intelligence.
The company also welcomes discussions with organizations interested in strategic alliances, joint ventures, and other collaborations across healthcare, biotechnology, medical innovation, and wellness. Leadership is available for interviews.
To apply, explore collaboration, or request an interview, contact [email protected] or visit aimwellbio.com.
About Aimwell Partners Inc.
Aimwell Partners Inc. (OTCID:AIMN) is the parent company of AimwellBio, an AI-powered healthcare intelligence network serving physicians, practices, researchers, healthcare executives, and life sciences organizations. The platform monitors regulatory, clinical, and competitive signals across institutional sources and synthesizes them into verified, source-traced intelligence. Learn more at aimwellbio.com.
Media Contact:
John Morgan, CEO
[email protected]
aimwellbio.com
Forward-Looking Statements
This release contains forward-looking statements within the meaning of applicable securities laws, including statements about anticipated platform features, network growth, and potential partnerships. These statements reflect current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Inbound inquiries may not result in executed relationships or revenue, and anticipated features may be delayed or may not launch. Aimwell Partners Inc. undertakes no obligation to update these statements except as required by law. This release does not constitute an offer to sell or a solicitation of an offer to buy securities.
References to inbound interest describe early-stage, non-binding inquiries and do not represent executed contracts, committed revenue, or realized outcomes. AimwellBio provides analytical and informational outputs to support organizational decision-making; it does not provide medical advice, regulatory guidance, investment recommendations, or legal counsel.
SOURCE: Aimwell Partners
View the original press release on ACCESS Newswire
Ch.Havering--AMWN